Herbas VPB

Print
EN | LT
LT - DETERMINATION OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS A DIAGNOSTIC MARKER FOR RENAL DISORDERS
EN - DETERMINATION OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS A DIAGNOSTIC MARKER FOR RENAL DISORDERS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. G01N 33/68
G01N 33/92
European patent
(11) Number of the document 3208616
(13) Kind of document T
(96) European patent application number 17152153.7
Date of filing the European patent application 2005-12-20
(97) Date of publication of the European application 2017-08-23
(45) Date of publication and mention of the grant of the patent 2018-09-26
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
637503 P 2004-12-20 US
719307 P 2005-09-21 US
Inventors
(72)
UTTENTHAL, Lars Otto, ES
JUANES, Margarita Ghiglione, ES
BANGERT, Kristian, DK
Grantee
(73) Antibodyshop A/S, Grusbakken 8, 2820 Gentofte, DK
Title
(54) DETERMINATION OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS A DIAGNOSTIC MARKER FOR RENAL DISORDERS
  DETERMINATION OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS A DIAGNOSTIC MARKER FOR RENAL DISORDERS